Operating Lease, Right-of-Use Asset of Neuphoria Therapeutics Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neuphoria Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Neuphoria Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $75,219, a 62% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $75,219 -$122,228 -62% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q1
Q2 2025 $102,612 -$114,363 -53% 30 Jun 2025 10-Q 17 Feb 2026 2025 Q2
Q1 2025 $125,213 31 Mar 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 $150,519 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2
Q3 2024 $197,447 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $216,975 -$113,503 -34% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $330,478 30 Jun 2023 10-K 30 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.